Krystal Biotech, Inc. · NASDAQ:KRYS

Krishnan Suma sold 25,000 Krystal Biotech, Inc. shares (Form 4)

Traded Sep 4, 2026 · Filed Sep 4, 2026

On Sep 4, 2026, Krishnan Suma (Director, President, R&D, 10% owner) sold 25,000 Krystal Biotech, Inc. shares at an average US$359.32 for US$8.98M under a trading plan, leaving 1,302,145 shares. Filed Sep 4, 2026 (Form 4).

Sold
25,000 shares
Price
US$359.32 average (US$354.54 to US$366.56)
Value
US$8.98M
Holding after
1,302,145 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President, R&D, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 4, 2026Common StockSale520US$354.541,326,625Direct
Sep 4, 2026Common StockSale2,006US$355.571,324,619Direct
Sep 4, 2026Common StockSale3,267US$356.371,321,352Direct
Sep 4, 2026Common StockSale3,962US$357.571,317,390Direct
Sep 4, 2026Common StockSale3,180US$358.421,314,210Direct
Sep 4, 2026Common StockSale3,392US$359.391,310,818Direct
Sep 4, 2026Common StockSale2,320US$360.471,308,498Direct
Sep 4, 2026Common StockSale1,242US$361.611,307,256Direct
Sep 4, 2026Common StockSale1,992US$362.651,305,264Direct
Sep 4, 2026Common StockSale565US$363.341,304,699Direct
Sep 4, 2026Common StockSale1,329US$364.481,303,370Direct
Sep 4, 2026Common StockSale826US$365.411,302,544Direct
Sep 4, 2026Common StockSale399US$366.561,302,145Direct

Source

View original at SEC

Related